Figure 4.
Figure 4. TCR-transduced T cells from healthy and CML donors can kill purified CD34+ cells of CML and AML patients. (A) The cytotoxicity of TCR-transduced CTLs of a healthy donor was tested against freshly isolated CD34+ cells of A2+ CML patients (CML1-3), an A2– CML4 control patient, and against fresh CD34+ cells isolated from an A2+ healthy donor (N-CD34). (B) TCR-transduced CTLs of a healthy donor were tested against CD34+ and CD34– cells purified of the A2+ patients CML5 and AML1. Filled symbols represent CD34+ cells and open symbols represent CD34–. (C) TCR-transduced CTLs of a CML patient were tested against CD34+ (•) and CD34– ◪) cells isolated from the A2+ AML2 patient, CD34+ cells from the A2+ CML5 patient, and fresh CD34+ cells from an A2+ healthy donor (N-CD34).

TCR-transduced T cells from healthy and CML donors can kill purified CD34+ cells of CML and AML patients. (A) The cytotoxicity of TCR-transduced CTLs of a healthy donor was tested against freshly isolated CD34+ cells of A2+ CML patients (CML1-3), an A2 CML4 control patient, and against fresh CD34+ cells isolated from an A2+ healthy donor (N-CD34). (B) TCR-transduced CTLs of a healthy donor were tested against CD34+ and CD34 cells purified of the A2+ patients CML5 and AML1. Filled symbols represent CD34+ cells and open symbols represent CD34. (C) TCR-transduced CTLs of a CML patient were tested against CD34+ (•) and CD34 ◪) cells isolated from the A2+ AML2 patient, CD34+ cells from the A2+ CML5 patient, and fresh CD34+ cells from an A2+ healthy donor (N-CD34).

Close Modal

or Create an Account

Close Modal
Close Modal